SCROLL NEWS / DISCOVERY

Search headlines

Find the stories shaping the conversation.

Search mode
Refine results
Active filters Keyword All time

Results for " Biotech " 274 found 🔀 AI-powered Shuffle

2026 Fellows Advancing Women's Health Research in Africa

Fellows from 11 countries represent a diverse group of researchers, clinicians, biotechnologists, and innovators committed to women's health research in Africa.

nam.edu logo
Apr 30 • 12:40 PM EDT • Health • nam.edu
One Health Microbiome Center names next doctoral interns for industry program

Two Penn State doctoral students will spend eight weeks in Germany at the headquarters of global biotechnology company QIAGEN. This marks the third year of the program, a partnership between the One Health Microbiome Center and QIAGEN.

psu.edu logo
Apr 27 • 8:00 AM EDT • Health • psu.edu
Rep. Erica Layon: Don't let politics stifle biotech innovation in Granite State

Forty-five minutes from the world’s largest biotech hub, New Hampshire has a chance to lead a medical revolution. Two bills before the Senate this month would make that happen. Democrats

unionleader.com logo
Apr 27 • 12:00 AM EDT • Politics • unionleader.com
Lab-Grown Sperm?! Cool Science or Sci-Fi Gone Wild

A biotech startup claims it’s created human sperm in a lab—sparking equal parts excitement, skepticism, and “wait… should we be doing this?”

nbcpalmsprings.com logo
Apr 24 • 8:00 PM EDT • Science • nbcpalmsprings.com
Canada’s biotech paradox: strong science, weak scaling

Canada produces a steady stream of biotech startups built on credible academic research. Universities and hospital research centers in Toronto, Montreal, and Vancouver generate discoveries that move quickly into company formation. Early-stage activity is not the constraint. The difficulty tends to surface later, when those companies try to grow.

thepharmaletter.com logo
Apr 23 • 8:00 AM EDT • Science • thepharmaletter.com
😐 Neutral (3%)
SPONSORED How small businesses help power Huntsville's growth

Huntsville, Ala.'s global reputation for aerospace, biotech and defense often grabs headlines. But the region's continued growth depends just as much on local entrepreneurs — and access to capital that helps them launch, hire and scale.

axios.com logo
Apr 22 • 2:00 PM EDT • Business • axios.com
High-Signal Publisher
Offworld Life Science: Research Hardware For A Biotechnology Investigation

configures research hardware inside a portable glovebag for a biotechnology investigation exploring how bacteria affect heart tissue in the microgravity environment.

astrobiology.com logo
Apr 22 • 11:44 AM EDT • Science • astrobiology.com
Crew Studies Biotech on Tuesday to Advance Health and Space Economy

Biotechnology research seeking to advance human health and the space economy packed the science schedule aboard the International Space Station on Tuesday. The Expedition 74 crew members also explored space physics, updated robotics software, and conducted an emergency drill.

nasa.gov logo
Apr 21 • 4:18 PM EDT • Health • nasa.gov
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East

NEWCASTLE, England, April 15, 2026--Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established a strategic partnership with JH Health Ltd, a Saudi Arabian company focused on medical and health-related technology. The partnership grants JH Health exclusive rights to use and distribute Atelerix’s hydrogel-based cell and tissue preservation solutions in the Middle East, significantl

finance.yahoo.com logo
Apr 15 • 4:05 AM EDT • Health • finance.yahoo.com
Pitt Team Shines in National Bioethics Competition

In an annual tournament where students debate ethical issues in medicine, biotechnology and health care, the Pitt team placed second.

health.pitt.edu logo
Apr 14 • 3:49 PM EDT • Health • health.pitt.edu
Abbott survey finds ‘information overload, confusion and cost’ affecting health choices in US

Too much information, uncertainty and financial worries are hitting Americans when it comes to making important choices for their health. | Too much information, uncertainty and financial worries are hitting Americans when it comes to making important choices for their health.

fiercepharma.com logo
Apr 10 • 9:10 AM EDT • Health • fiercepharma.com
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a potential best-in-class/first-in-class Claudin 18.2-directed bispecific antibody for gastric cancer, has shown robust and durable responses with broad CLDN18.2 activity, favorable safety, as well as potential eligibility for FDA’s Accelerated Approval Pathway with potential initiation of a registrationa

finance.yahoo.com logo
Apr 7 • 4:50 PM EDT • Business • finance.yahoo.com
Immunic COO highlights the importance of science-led innovation to mark World Health Day

Immunic Inc (NASDAQ:IMUX, FRA:10VA) chief operating officer Jason Tardio talked with Proactive's Stephen Gunnion about the importance of science-led innovation in tackling neurological diseases, particularly multiple sclerosis, on World Health Day 2026. Tardio highlighted that the biotech industry is fundamentally grounded in scientific research and data, noting that “everything we do is rooted in science.” He explained that Immunic is focused on developing innovative therapies designed to improve patient outcomes and address significant unmet medical needs. The discussion centred on multiple sclerosis (MS), a complex neurological disease that continues to present challenges despite decades of progress. Tardio pointed out that while advancements have been made, “the disease is not solved for,” with many patients still experiencing disability progression and requiring safer, more tolerable treatments. He emphasised the urgent need for innovation, particularly in progressive forms of MS where treatment options remain extremely limited. Immunic’s lead asset, vidofludimus calcium, is being developed as a novel approach aimed at addressing the full spectrum of the disease. Tardio also reinforced the broader mission of the healthcare and biotech sectors, stating that the ultimate goal is to help individuals “live a better quality of life” and “a healthier life longer.” Watch the full interview to learn more about Immunic’s approach to advancing MS treatment through science. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #Immunic #MultipleSclerosis #BiotechInnovation #Healthcare #MSResearch #DrugDevelopment #ClinicalTrials #Neurology #WorldHealthDay #ScienceDriven #VidofludimusCalcium #PharmaNews #BiotechNews

finance.yahoo.com logo
Apr 7 • 8:05 AM EDT • Science • finance.yahoo.com
Biotech layoffs return: Mass. life science firms cut 745 jobs in Q1

Biotech job cuts return: 14 companies cut 745 jobs in Q1

nbcboston.com logo
Apr 6 • 5:00 AM EDT • Science • nbcboston.com
Goldman is betting Nvidia will get a boost from health care as industry builds out AI capabilities

Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.

cnbc.com logo
Mar 31 • 9:59 AM EDT • Health • cnbc.com
Mantis Biotech is making 'digital twins' of humans to help solve medicine's data availability problem

Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the human body, representing anatomy, physiology and behavior.

techcrunch.com logo
Mar 30 • 10:30 AM EDT • Technology • techcrunch.com
Watch Hua Medicine on Earnings, Business Expansion Plans

Chinese biotech firm Hua Medicine sees robust growth in 2026 after reporting a 93% jump in full-year revenue. Speaking exclusively to Bloomberg's "The China Show," Chief Strategy Officer George Lin discusses the outlook for the company’s flagship drug dorzagliatin and plans to expand to additional markets.

bloomberg.com logo
Mar 29 • 8:00 PM EDT • Business • bloomberg.com
Scientists Stunned: Colossal Eggs Discovered 3,500 Meters Beneath an Active Volcano

Beneath an active seafloor volcano off Vancouver Island, researchers have documented a congregation of giant eggs at roughly 3,500 meters, a discovery that reframes how life can flourish under extreme conditions. The eggs belong to the Pacific white skate, an elusive deep‑sea species adapted to cold, crushing pressure and perpetual darkness. What seemed an unlikely nursery is actually a geothermally warmed refuge, where subtle heat helps embryos survive a marathon incubation. The finding links volcanic energy to a quiet engine of biodiversity, turning a hostile landscape into an incubator. A living volcano, a hidden nursery The seamount long assumed dormant now exhales mineral‑rich, shimmering plumes, proof of hydrothermal life at depth. Expedition cameras swept across black basalt and pale bacterial mats, revealing vents that pulse with warmth. That warmth, though modest by human standards, alters the physics of development for cold‑adapted embryos. In a realm where metabolism creeps, even a few degrees can mean faster growth and higher survival. The volcano is not only active; it is ecologically formative, drafting a blueprint for a thriving oasis. Giant eggs and a skate built for the abyss The Pacific white skate, Bathyraja spinosissima, is built for the abyss: broad wings, armored spines, and a life history that trades speed for endurance. Females lay outsized, rectangular “mermaid’s purses,” often 46–50 centimeters long, packed with rich yolk to fuel years of growth. In the frigid deep, embryos can require around four years to hatch, a timeline that magnifies every energetic advantage. The scale is striking—large eggs, large adults, and a textbook case of deep‑sea gigantism. The volcano’s gentle heat may literally shave months or years from the wait. Why heat matters at the bottom of the sea Hydrothermal circulation delivers low‑level warmth without the turbulence that would scatter fragile egg‑cases. Slightly elevated temperatures accelerate enzyme kinetics, nudging development along while keeping embryos within a safe range. Mineral‑laden fluids likely shape local microbiomes, which, in turn, can influence biofilms on egg surfaces. The environment acts like a slow, steady incubator, countering the deep sea’s tyrannies of cold and scarcity. For a species with long maturation and few offspring, every incremental boost compounds across generations. An ecosystem sculpted by fire and water Seafloor volcanoes create steep environmental gradients, stitching together hot vents, cool eddies, and mineral gardens into mosaic habitats. Microbes harvest chemical energy, seeding food webs that support crustaceans, fishes, and skates. Cameras documented egg‑cases nestled among rocky ledges, near communities nourished by vent‑driven chemistry. These islands of productivity behave like deep‑sea oases, sustaining life far beyond the vent orifice’s flickering light. The nursery’s success underscores how geological forces engineer biological opportunity. “Finding a cradle of life tucked beneath a breathing volcano reminds us that the planet’s harshest places can be profoundly generous.” What the discovery could change The nursery reframes conservation priorities in regions where volcanism quietly underwrites reproduction. Protecting hydrothermal corridors could safeguard entire lifecycles, not just charismatic adults spotted during occasional surveys. It also sharpens questions about how climate‑driven shifts in ocean circulation might influence vent activity, temperature fields, and embryo survival. With methodical mapping, time‑series cameras, and environmental DNA, scientists can track whether nurseries remain stable or drift with geologic rhythms. Key implications include: Enhanced understanding of deep‑sea reproduction at hydrothermal sites. New conservation targets centered on geothermal nurseries. Comparative studies with other volcanic regions, from the Galápagos to rift zones. Biotechnological insights from organisms adapted to long, cold development. Better models of how seafloor heat shapes regional biodiversity. Methods behind the revelation Remotely operated vehicles threaded through chimney fields, gathering video, temperatures, and mineral signatures. High‑definition imagery captured the distinctive, horned egg cases, their edges dusted with fine volcanic silt. Geochemical profiles mapped how heat and chemicals disperse, outlining the “thermal lanes” where eggs most cluster. Combined, these datasets reveal a nursery organized by geothermal topography, with egg‑cases concentrated in pockets of gentle, sustained warmth. A fragile boon in a changing ocean Deep‑sea environments feel remote, yet they intersect with global pressures: mining proposals, cable routes, and shifting oxygen levels. The nursery’s resilience hinges on stable heat flow, intact substrates, and minimal disturbance from noise or sediment. Safeguarding such places is not just about protecting novelty; it preserves a slow, ancient strategy that lets large, long‑lived animals endure in the coldest reaches of the Pacific. Where geology and biology meet, the planet’s deep time still writes living stories. This volcano‑warmed nursery adds a vital chapter to that story, revealing how subtle thermal gifts can tip the scales toward life in the abyss. With each dive, researchers trace the contours of an unseen world, where fire feeds water, and water—against all odds—feeds the future.

iowaparkleader.com logo
Mar 29 • 5:00 PM EDT • Science • iowaparkleader.com
😐 Neutral (1%)
wow
38%
love
33%
ahah
29%
Beauty Is A $667 Billion Business And Venture Capital Is Finally Paying Attention

As Cosmoprof Worldwide Bologna wraps its 57th edition this week, AI, biotech, and venture capital are converging on a sector that has long outpaced the attention it receives from institutional investors.

forbes.com logo
Mar 29 • 10:41 AM EDT • Business • forbes.com
San Antonio eyes ‘City of Science’ future as bioscience sector looks to scale

San Antonio must boost bioscience marketing, investment and workforce to compete with biotech hubs like Dallas and Houston, leaders say.

sanantonioreport.org logo
Mar 28 • 12:00 PM EDT • Science • sanantonioreport.org
Deep dive
😐 Neutral (14%)
wow
43%
love
31%
ahah
26%
Roseman University launches life science incubator to promote discoveries

Roseman University is launching a new life science incubator to support the growth of the biotechnology sector in Southern Nevada.

news3lv.com logo
Mar 26 • 2:21 PM EDT • Science • news3lv.com
How to Turn a Chicken Egg Into a Drug Factory

A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.

nytimes.com logo
Mar 26 • 9:00 AM EDT • Science • nytimes.com
Biotech Company Tivic Health Aims to Advance Immunotherapy Research Programs

Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding biologics development and manufacturing capabilities.

usatoday.com logo
Mar 25 • 2:13 PM EDT • Health • usatoday.com
😐 Neutral (10%)
love
100%
Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research

/PRNewswire/ -- Stealth BioTherapeutics (the "Company"), a commercial-stage biotechnology company focused on the discovery, development, and commercialization...

prnewswire.com logo
Mar 23 • 8:00 AM EDT • Business • prnewswire.com
Couple left biotech jobs to run a farm, how they keep marriage strong

Working together — in corporate jobs and with our own business — has taught us key strategies to help both our careers and marriage thrive.

businessinsider.com logo
Mar 21 • 12:25 PM EDT • Business • businessinsider.com
🙂 Positive (50%)
Seattle’s biotech scene is world-class — Life Science Washington is teaching it how to brag

Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.

geekwire.com logo
Mar 20 • 12:49 PM EDT • Science • geekwire.com
Curis Provides Fourth Quarter 2025 Business Update

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business update and financial results for the quarter ended December 31, 2025.

finance.yahoo.com logo
Mar 19 • 4:00 PM EDT • Business • finance.yahoo.com
Curis Provides Fourth Quarter 2025 Business Update

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule...

prnewswire.com logo
Mar 19 • 4:00 PM EDT • Business • prnewswire.com
A biotech turns to Apple Watch to study its Parkinson's drug

In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and more

statnews.com logo
Mar 19 • 9:48 AM EDT • Health • statnews.com
SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment

RANCHO CORDOVA, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term growth strategy across three business units: small molecule, peptides, and viral vectors. SK pharmteco is sharpening its strategy to provide pharmaceutical and biotechnology partners with the financial strength, technical rigor, and operational infrastructure needed for long-term

finance.yahoo.com logo
Mar 19 • 4:00 AM EDT • Business • finance.yahoo.com
DOE Announces $293 Million Genesis Mission Funding for Quantum Science and AI-Driven Research

DOE announces $293M Genesis Mission funding for AI-driven research in quantum information science, advanced manufacturing, biotechnology, and nuclear energy.

thequantuminsider.com logo
Mar 19 • 3:35 AM EDT • Science • thequantuminsider.com
New Grant to Grow Interdisciplinary Biochemistry Master’s Program

Dontae Mosley wasn’t sure graduate school was within his reach due to financial constraints, but thanks to the Interdisciplinary Biochemistry Master’s Program, he was able to pursue his master’s degree and launch his career in the biotech industry. Now, more biochemistry graduate students will have the same opportunity through a new grant from the National Science Foundation.

cals.ncsu.edu logo
Mar 16 • 10:25 AM EDT • Science • cals.ncsu.edu
More Than Just Metadata: Engineering a Healthier Future

How a current Gonzaga M.S. in Data Science student plans to use her degree in the biomedical or biotechnology industry to help improve well-being.

gonzaga.edu logo
Mar 12 • 3:55 PM EDT • Science • gonzaga.edu
😐 Neutral (20%)
ahah
38%
love
35%
wow
27%
Biomolecular profiling for noninvasive health monitoring

Nature Biotechnology - Kim et al. present mass spectrometry and wearable sensor technology as complementary approaches that, when integrated, can co-evolve to open new possibilities for noninvasive...

nature.com logo
Mar 11 • 8:00 PM EDT • Health • nature.com
Red states hit hardest by reduced NIH funding

Epstein's "great friend" returns to biotech, sex differences in suicide, and other health news from Morning Rounds

statnews.com logo
Mar 11 • 7:52 AM EDT • Health • statnews.com
Human Brain Cells Run New Data Centers in Singapore, Melbourne

Biotech startup Cortical Labs is working on two small data centers run by human brain cells, putting lab-grown neurons onto silicon in an experiment that could one day challenge chips from the likes of Nvidia Corp.

bloomberg.com logo
Mar 9 • 6:00 PM EDT • Technology • bloomberg.com
Exclusive | FDA’s Controversial Vaccines Chief Will Leave the Agency

Dr. Vinay Prasad will depart in April, after a year leading the division that approves vaccines and biotech drugs.

wsj.com logo
Mar 6 • 4:55 PM EST • Health • wsj.com
Community science inspires curiosity, inclusion, and discovery

The Yale School of Public Health collaborated with Celentano Biotech, Health and Medical Magnet School, and New Haven Public Schools, to create The Tree of

ysph.yale.edu logo
Mar 5 • 12:00 AM EST • Science • ysph.yale.edu
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026

VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to provide more effective and durable treatment than the current standard of care for patients with wet AMD, DME and RVO Visara, a NovaBridge Majority-Owned Subsidiary, Holds Global Rights to VIS-101 Outside of Greater China and Certain Asian Territories ROCKVILLE, Md., March 03, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform co

finance.yahoo.com logo
Mar 3 • 9:05 AM EST • Business • finance.yahoo.com
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 in CGD; plan to submit BLA following final alignment -- -- Prime Medicine reported cash, cash equivalents, investments, and restricted cash of $191M providing cash runway into 2027 -- CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company

finance.yahoo.com logo
Mar 3 • 8:00 AM EST • Business • finance.yahoo.com
Conexeu Sciences Appoints Jean-Romain (JR) Falconnet as Head of Business Development & Licensing

Reno, Nevada--(Newsfile Corp. - March 2, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation extracellular matrix platform, is pleased to announce Jean-Romain (JR) Falconnet as Head of Business Development & Licensing.In his role at Conexeu, JR will lead business development, licensing strategy, and strategic partnerships—supporting the company's growth roadmap and expanding opportunities to bring...

finance.yahoo.com logo
Mar 2 • 9:03 AM EST • Business • finance.yahoo.com
Codex Labs to Attend Health.tech Global Summit to Advance Root Cause Dermatology Innovation

BASEL, Switzerland - February 24, 2026 - Codex Labs, a biotech skincare company focused on integrative dermatology and

usatoday.xpr-gannett.com logo
Feb 24 • 6:04 PM EST • Health • usatoday.xpr-gannett.com
Agentic AI and the rise of in silico team science in biomedical research

Nature Biotechnology - This study examines the emerging use of agentic artificial intelligence (AI) in biomedical research, highlighting the challenges and opportunities that may inform the design...

nature.com logo
Feb 23 • 7:00 PM EST • Science • nature.com
NJ technical high schools foster innovative science research

Bergen County and Passaic County technical schools in NJ empower students with advanced science research and biotechnology programs.

njbiz.com logo
Feb 23 • 12:01 AM EST • Science • njbiz.com
Got $10,000? Axsome Therapeutics Could Be a Mental‑Health Moonshot by 2036

The biotech is slowly rising in prominence.

fool.com logo
Feb 22 • 1:00 AM EST • Health • fool.com
😐 Neutral (0%)
Bridging science and society in the emerging bioeconomy

A new MIT course, STS.059 (The Bioeconomy and Society), explores the social and political factors at work in the biology, biotech, and biological engineering sectors.

news.mit.edu logo
Feb 18 • 2:55 PM EST • Science • news.mit.edu
Scientists test “smart” nanotech to target cancer tumors with more precision

UC Davis scientists are researching “smart” nanoparticles that anchor to tumors and enable on‑demand delivery of cancer‑fighting therapies, boosting precision while protecting healthy tissue.

health.ucdavis.edu logo
Feb 12 • 7:00 PM EST • Health • health.ucdavis.edu
Building biopharma: The communities behind the science

Editor’s note: This is the first of a twice-monthly series that will highlight the vibrant communities that make up the biopharma industry. | What began as a small summit of women biotech CEOs five years ago has grown into a 350-member force gaining momentum, even as political headwinds force others to retreat.

fiercebiotech.com logo
Feb 12 • 9:30 AM EST • Science • fiercebiotech.com
🙂 Positive (36%)
wow
100%
Noubar Afeyan And Sally Kornbluth Talk MIT, Science

Davos MIT leaders urge defending scientific method; AI enables polyintelligence, biotech gains, and education.

forbes.com logo
Feb 11 • 6:40 PM EST • Science • forbes.com
Xtalks Announces its Life Science Webinar Calendar for February 2026

Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

finance.yahoo.com logo
Feb 2 • 8:30 AM EST • Science • finance.yahoo.com
Designing the future of metabolic health through tissue-selective drug delivery

Founded by MIT alumni, the biotech firm Gensaic develops protein carriers that can deliver therapeutic molecules to specific tissues and cells.

news.mit.edu logo
Jan 30 • 10:15 AM EST • Health • news.mit.edu
Deep dive
😐 Neutral (11%)
wow
74%
ahah
26%
Sepsis-finding biotech Prenosis lands $40M in financing, federal contract

Chicago-based sepsis diagnosing biotech Prenosis announced two $20 million milestones this morning, Series A financing and a large government contract.

chicagobusiness.com logo
Jan 30 • 6:16 AM EST • Business • chicagobusiness.com
Exclusive: VC firm Rock Health considering biotech investments

The San Francisco firm has invested almost exclusively in digital health for 15 years.

axios.com logo
Jan 27 • 4:46 PM EST • Health • axios.com
High-Signal Publisher
Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings

Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22 as the market digested weaknesses from its fourth-quarter and full-year earnings report.

fiercebiotech.com logo
Jan 23 • 8:05 AM EST • Business • fiercebiotech.com
Deep dive
😐 Neutral (5%)
wow
72%
love
28%
Mapping the science–technology translational landscape in biomedicine

Nature Biotechnology - A systematic, prospective analysis of the interplay between science and technology in biomedicine can illuminate the pathway for translating scientific insights into tangible...

nature.com logo
Jan 15 • 7:00 PM EST • Science • nature.com
BeOne CEO on Business Strategy, Biotech Outlook

John Oyler, Co-founder, Chairman and CEO at BeOne Medicines, discusses the company's business strategy and the outlook for the biotech sector. He speaks with Avril Hong and Paul Allen from the sidelines of the JPMorgan Healthcare Conference in San Francisco. (Source: Bloomberg)

bloomberg.com logo
Jan 14 • 10:47 PM EST • Business • bloomberg.com
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference

Exceeded 10,000 patients treated to date with CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy manufacturing facility in the U.S.Profitability expected in 2026, driven by continued CARVYKTI® revenue growth and operating margin expansion Treated first patient with in vivo pipeline candidate in investigator-initiated trial Preclinical data from primates provided early validat

finance.yahoo.com logo
Jan 12 • 8:00 AM EST • Business • finance.yahoo.com
Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise

Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced a strategic partnership with McKinney Regulatory Science Advisors ("McKinney"), a premier FDA regulatory consulting firm specializing in nicotine and reduced-risk consumer products, to spearhead its regulatory submission strategy and solidify its commitment to scientific leadership in the oral pouch technology space.

finance.yahoo.com logo
Jan 12 • 7:00 AM EST • Science • finance.yahoo.com
‘An undoing of the scientific method’: Flagship CEO warns of government threats to US biotech industry

The Trump administration spent 2025 taking a sledgehammer to science, obliteratin | The Trump administration spent 2025 taking a sledgehammer to science, obliterating funding and reshaping agencies like the FDA and National Institutes of Health through layoffs and restrictive new policies. In a new letter, Noubar Afeyan, Ph.D., co-founder of Moderna and CEO of Flagship Pioneering, warns that these actions risk undermining the foundations of science itself to the ultimate detriment of health and biotech innovation in America.

fiercebiotech.com logo
Jan 12 • 5:00 AM EST • Science • fiercebiotech.com
Investor behind Moderna says U.S. policy is ‘taking a sledgehammer to our miracle machine’

Noubar Afeyan, one of biotech’s top investors, says U.S. policy is "taking a sledgehammer to our miracle machine."

statnews.com logo
Jan 12 • 5:00 AM EST • Science • statnews.com
Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks

The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is changing.

bloomberg.com logo
Jan 8 • 7:15 AM EST • Health • bloomberg.com
😐 Neutral (21%)
love
50%
ahah
25%
wow
25%
New Era of Fermentation: SINOFN Health’s Global Health Vision

TIANJIN, TIANJIN, CHINA, January 5, 2026 /EINPresswire.com/ — In the wellness-driven era of 2025, the global beverage industry is witnessing a seismic shift from sugary sodas to functional, “alive” alternatives. As gut health becomes the cornerstone of modern vitality, one name has emerged at the intersection of biotechnology and consumer wellness: SINOFN Health Co., Ltd. […]

freep.com logo
Jan 4 • 6:22 PM EST • Health • freep.com
Editors Pick: Sense, Nonsense and Science Columns

Seed World Europe features the columns of Dr. Joe Schwarcz, Director of McGill University’s Office for Science and Society, for readers who appreciate science with clarity, curiosity, and wit. Known for demystifying chemistry and challenging misinformation, Joe brings an engaging, no-nonsense voice to topics spanning food, biotechnology, health claims, and the science behind everyday phenomena. Each column helps readers separate evidence from hype while exploring how science shapes our world—and the seed sector.

seedworld.com logo
Dec 31, 2025 • 2:22 AM EST • Science • seedworld.com
'Stop and re-check everything': Scientists discover 26 new bacterial species in NASA's cleanrooms

Scientists discover 26 new bacterial species in NASA cleanrooms, revealing surprisingly resilient microbes with potential uses in biotechnology and medicine.

livescience.com logo
Dec 29, 2025 • 7:00 AM EST • Science • livescience.com
Deep dive
😐 Neutral (6%)
wow
51%
ahah
49%
Biotech, cannabis, housing, ag all made business headlines in 2025

In The Star's annual year in review, the county's biggest business stories included housing proposals and the aftermath of a major immigration raid.

vcstar.com logo
Dec 26, 2025 • 10:30 AM EST • Business • vcstar.com
Deep dive
😐 Neutral (5%)
wow
66%
ahah
34%
Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update

PALO ALTO, Calif., December 11, 2025--Evommune, Inc. (NYSE: EVMN) (the "Company"), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a business update.

finance.yahoo.com logo
Dec 11, 2025 • 4:05 PM EST • Business • finance.yahoo.com
Moderna Founder Warns US Doubts on Science Threaten Biotech Edge

The US risks falling behind in biotechnology as the government cuts funding and skepticism over vaccines grows, according to Moderna Inc.’s co-founder and Chairman Noubar Afeyan.

bloomberg.com logo
Dec 11, 2025 • 5:15 AM EST • Science • bloomberg.com
Chinese scientists develop promising stem cell therapy for Parkinson’s

New biotech allows ‘seeds’ planted in the brain to differentiate into new nerve cells, reshaping its neural network.

scmp.com logo
Dec 6, 2025 • 5:00 PM EST • Science • scmp.com
Conejo Valley’s life science moment has arrived

The Conejo Valley’s life science moment is here — driven by global leaders, emerging innovators, modern infrastructure, and a skilled workforce.

vcstar.com logo
Dec 6, 2025 • 10:00 AM EST • Science • vcstar.com
City of Hope, Hoag and UCI Health chose to build in Irvine, what makes the area attractive for health-care investment?

The billions of dollars in investments coming online more than double the number of hospital beds in the city, add thousands of jobs and makes Irvine a “biomedical, biotechnical” center…

ocregister.com logo
Dec 6, 2025 • 9:21 AM EST • Health • ocregister.com
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a more active global player in the fast-growing animal health sector.

finance.yahoo.com logo
Dec 2, 2025 • 9:00 AM EST • Health • finance.yahoo.com
Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer

MUTTENZ, Switzerland, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company pioneering innovation in peritoneal dialysis (PD), is pleased to announce the appointment of Andreas Schuh as Chief Financial Officer (CFO), effective December 1, 2025. Andreas Schuh joins Opterion with over 20 years of leadership experience across biotech, pharma, and medical devices. He has held senior finance and operations roles at Nuclidium, Jeito, Roivant, Novartis, and Al

finance.yahoo.com logo
Dec 1, 2025 • 2:00 AM EST • Health • finance.yahoo.com
Trump administration science assault slams major Bay Area economic engine, threatens ‘amazing innovations’

Investors and young scientists are pulling back from biotech, amid broader attacks on science under Trump, industry representatives said.

mercurynews.com logo
Nov 30, 2025 • 9:00 AM EST • Science • mercurynews.com
Trump administration science assault slams major Bay Area economic engine, threatens ‘amazing innovations’

Investors and young scientists are pulling back from biotech, amid broader attacks on science under Trump, industry representatives said.

mercurynews.com logo
Nov 30, 2025 • 9:00 AM EST • Science • mercurynews.com